276 related articles for article (PubMed ID: 15843997)
21. AIDS vaccine development in primate models.
Almond NM; Heeney JL
AIDS; 1998; 12 Suppl A():S133-40. PubMed ID: 9632994
[No Abstract] [Full Text] [Related]
22. Surrogates of protection in repeated low-dose challenge experiments.
Long DM; Hudgens MG; Wu CD
Stat Med; 2015 May; 34(10):1747-60. PubMed ID: 25628249
[TBL] [Abstract][Full Text] [Related]
23. Genetically identical primate modelling systems for HIV vaccines.
Kent SJ; Lewis IM
Reprod Fertil Dev; 1998; 10(7-8):651-7. PubMed ID: 10612472
[TBL] [Abstract][Full Text] [Related]
24. The use of nonhuman primate models of HIV infection for the evaluation of antiviral strategies.
Van Rompay KK
AIDS Res Hum Retroviruses; 2012 Jan; 28(1):16-35. PubMed ID: 21902451
[TBL] [Abstract][Full Text] [Related]
25. HIV vaccine development.
Singh M; Jeang KT; Smith SM
Front Biosci; 2005 Sep; 10():2064-81. PubMed ID: 15970479
[TBL] [Abstract][Full Text] [Related]
26. Particle-based vaccines for HIV-1 infection.
Young KR; Ross TM
Curr Drug Targets Infect Disord; 2003 Jun; 3(2):151-69. PubMed ID: 12769792
[TBL] [Abstract][Full Text] [Related]
27. Progress and challenges in therapies for AIDS in nonhuman primate models.
Haigwood NL
J Med Primatol; 1999; 28(4-5):154-63. PubMed ID: 10593480
[TBL] [Abstract][Full Text] [Related]
28. HIV vaccine development.
Watkins DI
Top HIV Med; 2010; 18(2):35-6. PubMed ID: 20516522
[TBL] [Abstract][Full Text] [Related]
29. Worldwide survey of AIDS vaccine challenge studies in nonhuman primates: vaccines associated with active and passive immune protection from live virus challenge.
Warren JT; Dolatshahi M
J Med Primatol; 1992; 21(2-3):139-86. PubMed ID: 1433265
[TBL] [Abstract][Full Text] [Related]
30. Prospects for vaccine protection against HIV-1 infection and AIDS.
Letvin NL; Barouch DH; Montefiori DC
Annu Rev Immunol; 2002; 20():73-99. PubMed ID: 11861598
[TBL] [Abstract][Full Text] [Related]
31. Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates.
García-Arriaza J; Perdiguero B; Heeney J; Seaman M; Montefiori DC; Labranche C; Yates NL; Shen X; Tomaras GD; Ferrari G; Foulds KE; McDermott A; Kao SF; Roederer M; Hawkins N; Self S; Yao J; Farrell P; Phogat S; Tartaglia J; Barnett SW; Burke B; Cristillo A; Weiss D; Lee C; Kibler K; Jacobs B; Asbach B; Wagner R; Ding S; Pantaleo G; Esteban M
J Virol; 2015 Aug; 89(16):8525-39. PubMed ID: 26041302
[TBL] [Abstract][Full Text] [Related]
32. Effects of virus burden and chemokine expression on immunity to SHIV in nonhuman primates.
Waterman PM; Kitabwalla M; Hatfield GS; Evans PS; Lu Y; Tikhonov I; Bryant JL; Pauza CD
Viral Immunol; 2004; 17(4):545-57. PubMed ID: 15671751
[TBL] [Abstract][Full Text] [Related]
33. Development of an AIDS vaccine using Sendai virus vectors.
Ishii H; Matano T
Vaccine; 2015 Nov; 33(45):6061-5. PubMed ID: 26232346
[TBL] [Abstract][Full Text] [Related]
34. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.
Shiver JW; Fu TM; Chen L; Casimiro DR; Davies ME; Evans RK; Zhang ZQ; Simon AJ; Trigona WL; Dubey SA; Huang L; Harris VA; Long RS; Liang X; Handt L; Schleif WA; Zhu L; Freed DC; Persaud NV; Guan L; Punt KS; Tang A; Chen M; Wilson KA; Collins KB; Heidecker GJ; Fernandez VR; Perry HC; Joyce JG; Grimm KM; Cook JC; Keller PM; Kresock DS; Mach H; Troutman RD; Isopi LA; Williams DM; Xu Z; Bohannon KE; Volkin DB; Montefiori DC; Miura A; Krivulka GR; Lifton MA; Kuroda MJ; Schmitz JE; Letvin NL; Caulfield MJ; Bett AJ; Youil R; Kaslow DC; Emini EA
Nature; 2002 Jan; 415(6869):331-5. PubMed ID: 11797011
[TBL] [Abstract][Full Text] [Related]
35. Vaccine development against HIV-1: current perspectives and future directions.
Edgeworth RL; San JH; Rosenzweig JA; Nguyen NL; Boyer JD; Ugen KE
Immunol Res; 2002; 25(1):53-74. PubMed ID: 11868934
[TBL] [Abstract][Full Text] [Related]
36. Reappraising the Value of HIV-1 Vaccine Correlates of Protection Analyses.
Klasse PJ; Moore JP
J Virol; 2022 Apr; 96(8):e0003422. PubMed ID: 35384694
[TBL] [Abstract][Full Text] [Related]
37. Variability of viral load in plasma of rhesus monkeys inoculated with simian immunodeficiency virus or simian-human immunodeficiency virus: implications for using nonhuman primate AIDS models to test vaccines and therapeutics.
Parker RA; Regan MM; Reimann KA
J Virol; 2001 Nov; 75(22):11234-8. PubMed ID: 11602764
[TBL] [Abstract][Full Text] [Related]
38. No vaccine against HIV yet--are we not perfectly equipped?
Singh M
Virol J; 2006 Aug; 3():60. PubMed ID: 16939652
[TBL] [Abstract][Full Text] [Related]
39. Progress and obstacles in the development of an AIDS vaccine.
Letvin NL
Nat Rev Immunol; 2006 Dec; 6(12):930-9. PubMed ID: 17124514
[TBL] [Abstract][Full Text] [Related]
40. Update on mucosal HIV vaccine vectors.
Duerr A
Curr Opin HIV AIDS; 2010 Sep; 5(5):397-403. PubMed ID: 20978380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
